CN Patent

CN119019454A — 一种杂芳基衍生物的制备及用途

Assigned to Guangzhou Zhirui Medical Technology Co ltd · Expires 2024-11-26 · 1y expired

What this patent protects

本发明涉及一种杂芳基衍生物的制备及用途，所述的杂芳基衍生物能够用于治疗或预防与抑制一种或多种激酶活性相关的疾病，涉及医药领域。该杂芳基衍生物及其立体异构体、前体药物、溶剂化物、多晶型物、水合物、氘化类似物、前药、药学上可接受的盐或赋形剂作为活性成分在制备预防或治疗中枢神经系统疾病、癌症及免疫性疾病药物组合物中的应用。

USPTO Abstract

本发明涉及一种杂芳基衍生物的制备及用途，所述的杂芳基衍生物能够用于治疗或预防与抑制一种或多种激酶活性相关的疾病，涉及医药领域。该杂芳基衍生物及其立体异构体、前体药物、溶剂化物、多晶型物、水合物、氘化类似物、前药、药学上可接受的盐或赋形剂作为活性成分在制备预防或治疗中枢神经系统疾病、癌症及免疫性疾病药物组合物中的应用。

Drugs covered by this patent

Patent Metadata

Patent number
CN119019454A
Jurisdiction
CN
Classification
—
Expires
2024-11-26
Drug substance claim
No
Drug product claim
No
Assignee
Guangzhou Zhirui Medical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.